DPW
AMPH icon

DiNuzzo Private Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

DiNuzzo Private Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$124 – 1369
2023
Q4 		$124 Buy
+2
New +$105 ﹤0.01% 1294

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

DiNuzzo Private Wealth's AMPH Position: Q1 2024 in Review

DiNuzzo Private Wealth sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 2 shares — an estimated $124 sold.

DiNuzzo Private Wealth first reported a position in AMPH in Q4 2023 and held it in 1 quarter. The position peaked at $124 in Q4 2023. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • DiNuzzo Private Wealth reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 2 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $124.
  • DiNuzzo Private Wealth first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • DiNuzzo Private Wealth's Amphastar Pharmaceuticals position peaked at $124 in Q4 2023.
  • 270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on DiNuzzo Private Wealth's 13F filing for Q1 2024, filed 6 May 2024.